| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
EVP Of Research | Ex Vice President Of Research
1 company
Huizinga Robert Bindert is an EVP Of Research at Aurinia Pharmaceuticals Inc.. Recent SEC Form 4 filings include 0 buys and 8 sells.
Estimated insider holdings value: $1.1M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 2, 2022 | AUPH Aurinia Pharmaceuticals Inc. | EVP Of Research | Sell | 4,849 | $12.01 | $58,236.49 | -6.5% | -2.9% | -23.1% | |
| Oct 25, 2021 | AUPH Aurinia Pharmaceuticals Inc. | EVP Of Research | Sale+OE | 130,000 | $29.75 | $3,867,500.00 | -66.4% | -47.3% | -75.2% | |
| Sep 21, 2021 | AUPH Aurinia Pharmaceuticals Inc. | EVP Of Research | Sale+OE | 32,500 | $23.99 | $779,533.04 | -13.6% | -7.0% | -67.0% | |
| Sep 14, 2021 | AUPH Aurinia Pharmaceuticals Inc. | EVP Of Research | Sell | 32,500 | $21.15 | $687,325.00 | -8.1% | -7.4% | -65.2% | |
| Sep 7, 2021 | AUPH Aurinia Pharmaceuticals Inc. | EVP Of Research | Sell | 5,000 | $18.30 | $91,500.00 | -3.5% | +5.5% | -63.3% |